Sažetak
Objective To determine if serum levels of retinoid protein-like protein 1 (VILIP-1), Platelet-Activating Factor Acetylhydrolase (PAF-AH), and 8-hydroxydeoxyguanosine (8-OHDG) are prognostic of a poor prognosis in patients with hypertensive intracerebral hemorrhage.
Methods The 194 patients in the cerebral hemorrhage group were hospitalized for hypertensive cerebral hemorrhage between January 2022 and January 2024. Forty-five healthy individuals who underwent concurrent physical examinations at the hospital were selected to form the healthy control group. To observe the differences in the levels of serum PAF-AH, VILIP-1 and 8-OHDG, the relationship with the amount of intracerebral hemorrhage, the severity of intracerebral hemorrhage and poor prognosis, and how effectively it predicts the bad outcome of patients suffering from hypertensive intracerebral hemorrhage.
Results Serum PAF-AH, VILIP-1, and 8-OHDG levels were substantially greater in the brain hemorrhage group than in the healthy control group (P<0.05). The levels of serum PAF-AH, VILIP-1 and 8-OHDG in the cerebral hemorrhage group increased with the increase of the amount of cerebral hemorrhage and the severity of nerve defect, and patients with poor prognoses had significantly greater serum levels of PAF-AH, VILIP-1, and 8-OHDG than patients with excellent prognoses (P<0.05). The levels of serum PAF-AH, VILIP-1 and 8-OHDG have high value in predicting the poor prognosis of patients with cerebral hemorrhage. The combined detection's area under the curve (AUC) was 0.925, its sensitivity was 95.4%, and its specificity was 71.2%. The AUC of the three indicators found independently did not differ statistically significantly (P>0.05).
Conclusion PAF-AH, VILIP-1 and 8-OHDG are involved in the occurrence and development process of hypertensive intracerebral hemorrhage. The increase of their levels is related to poor prognosis. Combined detection is helpful to improve the predictive efficacy of poor prognosis in patients with hypertensive intracerebral hemorrhage.
Ključne reči
Array
Array
Array
Array
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.